切换至 "中华医学电子期刊资源库"

中华消化病与影像杂志(电子版) ›› 2020, Vol. 10 ›› Issue (04) : 167 -173. doi: 10.3877/cma.j.issn.2095-2015.2020.04.006

所属专题: 文献

综述

27-羟基胆固醇在消化道肿瘤中增殖侵袭的影响及作用机制
李昌达1, 路菲凡2, 王广川3, 史永军3,()   
  1. 1. 250021 济南,山东大学附属省立医院
    2. 250021 济南,山东第一医科大学附属省立医院
    3. 250021 济南,山东第一医科大学附属省立医院 山东省立医院消化内科
  • 收稿日期:2020-05-14 出版日期:2020-08-01
  • 通信作者: 史永军
  • 基金资助:
    山东省重点研发计划(2016GSF201002); 济南临床医学科技创新计划(201602166)

Effects and mechanisms of 27-hydroxycholesterol on proliferation and invasion of gastrointestinal tumors

Changda Li1, Feifan Lu2, Guangchuan Wang3, Yongjun Shi3,()   

  1. 1. Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, China
    2. Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, China
    3. Department of Gastroenterology, Shandong Provincial Hospital, Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, China
  • Received:2020-05-14 Published:2020-08-01
  • Corresponding author: Yongjun Shi
  • About author:
    Corresponding author: Shi Yongjun, Email:
引用本文:

李昌达, 路菲凡, 王广川, 史永军. 27-羟基胆固醇在消化道肿瘤中增殖侵袭的影响及作用机制[J/OL]. 中华消化病与影像杂志(电子版), 2020, 10(04): 167-173.

Changda Li, Feifan Lu, Guangchuan Wang, Yongjun Shi. Effects and mechanisms of 27-hydroxycholesterol on proliferation and invasion of gastrointestinal tumors[J/OL]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2020, 10(04): 167-173.

27-羟基胆固醇作为胆固醇氧化产物之一,在体循环中含量丰富,生物学活性复杂,除了雌激素受体(ER)调节剂活性外,还可以通过非肝X受体(LXR)途径及LXR途径参与胆固醇代谢调节,影响肿瘤细胞的增殖、凋亡过程。此外,27-羟基胆固醇还可以通过调节免疫细胞功能及细胞的促炎因子分泌,影响肿瘤微环境和肿瘤转移。但是目前关于其在消化道肿瘤中的影响及作用机制方面的研究较少,通过结合既往在其他类型肿瘤中的研究进行综述,为研究27-羟基胆固醇与消化道肿瘤的作用机制提供新的参考。

As one of the cholesterol oxidation products, 27-hydroxycholesterol level is rich in the systemic circulation and its biologically actives are complex.Besides estrogen receptor(ER)regulator activity, it can also participate in the regulation of cholesterol metabolism through non-liver X receptor(LXR)and LXR pathways, thus affect the proliferation and apoptosis process of tumor cells.In addition, 27-hydroxycholesterol can affect the tumor microenvironment and tumor metastasis by regulating the function of immune cells and the secretion of pro-inflammatory cytokines.However, there are few studies on its effect and mechanism in gastrointestinal tumors at present.This review, combined with previous studies on other types of tumors, provides a new reference for the study on the relationship between 27-hydroxycholesterol and gastrointestinal tumors.

图1 27-羟基胆固醇在肿瘤中的作用机制
图2 27-羟基胆固醇与消化道肿瘤的关系
图3 诱导核外信号的级联反应
1
Goldstein JL,DeBose-Boyd RA,Brown MS.Protein sensors for membrane sterols[J].Cell,2006,124:35-46.
2
Tang W,Norlin M.Regulation of steroid hydroxylase CYP7B1 by androgens and estrogens in prostate cancer LNCaP cells[J]. Biochem Biophys Res Commun,2006,344(2):540-546.
3
Ishikawa T,Yuhanna IS,Umetani J,et al.LXRβ/estrogen receptor-αsignaling in lipid rafts preserves endothelial integrity[J].J Clin Invest,2013,123(8):3488-3497.
4
DuSell CD,Michihisa U, Philip WS,et al.27-hydroxycholesterol is an endogenous selective estrogen receptor modulator[J].Mol Endocrinol,2008,22:65-77.
5
Endo-Umeda K,Yasuda K,Sugita K,et al.7-Dehydrocholesterol metabolites produced by sterol 27-hydroxylase(CYP27A1)modulate liver X receptor activity[J].J Steroid Biochem Mol Biol,2014,140:7-16.
6
Li T,Chen W,Chiang JY.PXR induces CYP27A1 and regulates cholesterol metabolism in the intestine[J]. J Lipid Res,2007,48(2):373-384.
7
Quinn CM,Jessup W,Wong J,et al. Expression and regulation of sterol 27-hydroxylase(CYP27A1)in human macrophages:a role for RXR and PPARgamma ligands[J]. Biochem,2005,385: 823-830.
8
Li YC,Park MJ,Ye SK,et al.Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents[J].Am J Pathol,2006,168(quiz 1404-1405):1107-1118.
9
Baek AE,Yu YA,He S,et al.The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells[J].Nat Commun,2017,8(1):864.
10
Radhakrishnan A,Ikeda Y,Kwon H,et al.Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi:oxysterols block transport by binding to Insig[J].Proc Natl,2007,104:6511-6518.
11
Khan NA,Stopsack KH,Allott EH,et al.Intratumoral Sterol-27-Hydroxylase(CYP27A1)Expression in Relation to Cholesterol Synthesis and Vitamin D Signaling and Its Association with Lethal Prostate Cancer[J]. Cancer Epidemiol Biomarkers Prev,2019,28(6):1052-1058.
12
Alfaqih MA,Nelson ER,Liu W,et al.CYP27A1 Loss Dysregulates Cholesterol Homeostasis in Prostate Cancer[J].Cancer Res,2017,77(7):1662-1673.
13
Raza S,Meyer M,Goodyear C,et al.The cholesterol metabolite 27-hydroxycholesterol stimulates cell proliferation via ERβin prostate cancer cells[J].Cancer Cell Int,2017,17:52.
14
Hansson M,Ellis E,Hunt MC,et al.Marked induction of sterol 27-hydroxylase activity and mRNA levels during differentiation of human cultured monocytes into macrophages[J].Biochim Biophys Acta,2003,1593(2/3):283-289.
15
Guo D,Reinitz F,Youssef M,et al.An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway[J].Cancer Discov, 2011, 1: 442-456.
16
Wang Q,Ma X,Chen Y,et al.Identification of interferon-γas a new molecular target of liver X receptor[J].Biochem J,2014,459: 345-354.
17
Kim SM,Lee SA,Kim BY,et al.27-Hydroxycholesterol induces recruitment of monocytic cells by enhancing CCL2 production[J]. Biochem Biophys Res Commun,2013,442(3/4):159-164.
18
Gilligan LC,Gondal A,Tang V,et al.Estrone Sulfate Transport and Steroid Sulfatase Activity in Colorectal Cancer:Implications for Hormone Replacement Therapy[J]. Front Pharmacol, 2017,8:103.
19
Savic D,Ramaker RC,Roberts BS,et al.Distinct gene regulatory programs define the inhibitory effects of liver X receptors and PPARG on cancer cell proliferation[J]. Genome Med,2016,8(1):74.
20
Uno S,Endo K,Jeong Y,et al.Suppression ofβ-catenin signaling by liver X receptor ligands[J].Biochem Pharmacol,2009,77:186-195.
21
Ogola BO,Zimmerman MA,Sure VN,et al.G Protein-Coupled Estrogen Receptor Protects From Angiotensin II-Induced Increases in Pulse Pressure and Oxidative Stress[J]. Front Endocrinol(Lausanne),2019,10:586.
22
Jacenik D,Beswick EJ,Krajewska WM,et al.G protein-coupled estrogen receptor in colon function,immune regulation and carcinogenesis[J]. World J Gastroenterol,2019,25(30):4092-4104.
23
Pommier AJ,Alves G,Viennois E,et al.Liver X Receptor activation downregulates AKT survival signaling in lipid rafts and induces apoptosis of prostate cancer cells[J].Oncogene, 2010, 29: 2712-2723.
24
Rossin D,Dias IHK,Solej M,et al.Increased production of 27-hydroxycholesterol in human colorectal cancer advanced stage:Possible contribution to cancer cell survival and infiltration[J]. Free Radic Biol Med,2019,136:35-44.
25
国家消化内镜专业质控中心,国家消化系统疾病临床医学研究中心(上海),国家消化道早癌防治中心联盟,等. 中国早期食管癌及癌前病变筛查专家共识意见(2019年,新乡)[J]. 中华健康管理学杂志,2019,13(6):465-473.
26
Sardana RK,Chhikara N,Tanwar B,et al.Dietary impact on esophageal cancer in humans:a review[J]. Food Funct,2018,9(4):1967-1977.
27
Münch NS,Fang HY,Ingermann J,et al.High-Fat Diet Accelerates Carcinogenesis in a Mouse Model of Barrett′s Esophagus via Interleukin 8 and Alterations to the Gut Microbiome[J].Gastroenterology,2019,157(2):492-506.e2.
28
Wulaningsih W,Garmo H,Holmberg L,et al.Serum Lipids and the Risk of Gastrointestinal Malignancies in the Swedish AMORIS Study[J].J Cancer Epidemiol,2012,2012:792034.
29
Wang Y,Li H,Diao Y,et al.Relationship between oxidized LDL antibodies and different stages of esophageal carcinoma[J].Arch Med Res,2008,39(8):760-767.
30
Deng H,Zhou T,Mo X,et al.Low-density lipoprotein promotes lymphatic metastasis of esophageal squamous cell carcinoma and is an adverse prognostic factor[J].Oncol Lett,2019,17(1):1053-1061.
31
Zhou C,Zhong X,Gao P,et al.Statin use and its potential therapeutic role in esophageal cancer:a systematic review and meta-analysis[J]. Cancer Manag Res,2019,11:5655-5663.
32
Yuan Q,Dong CD,Ge Y,et al.Proteome and phosphoproteome reveal mechanisms of action of atorvastatin against esophageal squamous cell carcinoma[J]. Aging(Albany NY),2019,11(21):9530-9543.
33
Konturek PC,Burnat G,Hahn EG.Inhibition of Barret′s adenocarcinoma cell growth by simvastatin:involvement of COX-2 and apoptosis-related proteins[J]. J Physiol Pharmacol,2007,58 Suppl 3:141-148.
34
Ding Y,Shimada Y,Maeda M,et al.Association of CC chemokine receptor 7 with lymph node metastasis of esophageal squamous cell carcinoma.Clin Cancer Res [J].Carroll KK.Dietary fats and cancer,1991,53(4 Suppl):1064S-1067S.
35
Sauer SJ,Tarpley M,Shah I,et al.Bisphenol A activates EGFR and ERK promoting proliferation,tumor spheroid formation and resistance to EGFR pathway inhibition in estrogen receptor-negative inflammatory breast cancer cells[J]. Carcinogenesis,2017,38(3):252-260.
36
Jiang R,Yang Y,Huang Q,et al.Immunohistochemical expression of estrogen receptorα,Bcl-2 and NF-κB P65 in the polyps of patients with and without endometriosis [J]. J Obstet Gynaecol Res,2020,10.1111/jog.14370.
37
Zhu YH,Jeong S,Wu M,et al.Dietary Intake of Fatty Acids,Total Cholesterol,and Stomach Cancer in a Chinese Population[J]. Nutrients,2019,11(8):1730.
38
Eichholzer M,Stahelin HB,Gutzwiller F,et al.Association of low plasma cholesterol with mortality for cancer at various sites in men:17-y follow-up of the prospective Basel study[J].Am J Clin Nutr,2000,71:569-574.
39
Lim SC,Parajuli KR,Duong HQ,et al.Cholesterol induces autophagic and apoptotic death in gastric carcinoma cells[J]. Int J Oncol,2014,44(3):805-811.
40
Hong W,Guo F,Yang M,et al.Hydroxysteroid sulfotransferase 2B1 affects gastric epithelial function and carcinogenesis induced by a carcinogenic agent[J].Lipids Health Dis,2019,18(1):203.
41
Fenghua Guo,Wenting Hong,Mingjie Yang,Dongke Xu,Qianming Bai,Xiaobo Li,Zongyou Chen.Upregulation of 24(R/S),25-epoxycholesterol and 27-hydroxycholesterol suppresses the proliferation and migration of gastric cancer cells[J].Biochem BiophysRes Commun,2018,504(4):892-898.
42
Chang WC,Huang SF,Lee YM,et al.Cholesterol import and steroidogenesis are biosignatures for gastric cancer patient survival[J]. Oncotarget,2017,8(1):692-704.
43
Amemiya-Kudo M,Oka J,Takeuchi Y,et al.Suppression of the pancreatic duodenal homeodomain transcription factor-1(Pdx-1)promoter by sterol regulatory element-binding protein-1c(SREBP-1c)[J].J Biol Chem,2011,286(32):27902-27914.
44
Chen H,Qin S,Wang M,et al.Association between cholesterol intake and pancreatic cancer risk:evidence from a meta-analysis[J].Sci Rep,2015,5:8243.
45
Candelaria NR,Addanki S,Zheng J,et al.Antiproliferative effects and mechanisms of liver X receptor ligands in pancreatic ductal adenocarcinoma cells[J].PLoS One,2014,9(9):e106289.
46
Dwyer JR,Sever N,Carlson M,et al.Oxysterols are novel activators of the hedgehog signaling pathway in pluripotent mesenchymal cells[J].J Biol Chem,2007,282(12):8959-8968.
47
Soncini M,Corna G,Moresco M,et al.24-Hydroxycholesterol participates in pancreatic neuroendocrine tumor development[J].Proc Natl Acad Sci U S A,2016,113(41):E6219-E6227.
48
Roberg-Larsen H,Lund K,Vehus T,et al.Highly automated nano-LC/MS-based approach for thousand cell-scale quantification of side chain-hydroxylated oxysterols[J]. J Lipid Res,2014,55(7):1531-1536.
49
Bieghs V,Hendrikx T,van Gorp PJ,et al.The cholesterol derivative 27-hydroxycholesterol reduces steatohepatitis in mice[J]. Gastroenterology,2013,144(1):167-178.e1.
50
Li D,Long W,Huang R,et al.27-Hydroxycholesterol Inhibits Sterol Regulatory Element-Binding Protein 1 Activation and Hepatic Lipid Accumulation in Mice[J]. Obesity(Silver Spring),2018,26(4):713-722.
51
Ma D,Liu W,Wang Y.ApoA-I or ABCA1 expression suppresses fatty acid synthesis by reducing 27-hydroxycholesterol levels[J]. Biochimie,2014,103:101-108.
52
Heverin M,Ali Z,Olin M,et al.On the regulatory importance of 27-hydroxycholesterol in mouse liver[J]. J Steroid Biochem Mol Biol,2017,169:10-21.
[1] 李成功, 郑敏超, 陈志强, 商中华. TCN1在消化道肿瘤中作用机制的研究进展[J/OL]. 中华普通外科学文献(电子版), 2024, 18(01): 62-65.
[2] 王铭池, 梁乐琦, 刘永达. 基于NHANES数据库分析血脂与肾结石之间的关系[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 485-490.
[3] 杨阳, 王琤, 周文土, 周冰. Caveolae/Caveolin-1与膜胆固醇共同调控小鼠BMSCs成骨分化[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(03): 137-142.
[4] 陈显育, 曾谣, 莫钊鸿, 翟航, 张广权, 钟造茂, 陈署贤. 生物信息学分析CETP基因在肝癌中表达及其对预后和免疫的影响[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(02): 214-219.
[5] 苏振宏, 黄玉迪, 解举民. 施奈德结晶状角膜营养不良致病基因功能的研究进展[J/OL]. 中华眼科医学杂志(电子版), 2021, 11(05): 296-300.
[6] 于迪, 于海波, 吴焕成, 李玉明, 苏彬, 陈馨. 发状分裂相关增强子1差异表达对胆固醇刺激下血管内皮细胞的影响[J/OL]. 中华脑科疾病与康复杂志(电子版), 2023, 13(05): 264-270.
[7] 丁亚琴, 方旭, 戴彦成. 基于紧密型医联体的“一免三优先政策”在基层消化道肿瘤筛查中的应用探讨[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 481-484.
[8] 宗晓琳, 金宏威. 染色体外环状DNA在消化道肿瘤检测中的应用前景[J/OL]. 中华消化病与影像杂志(电子版), 2022, 12(03): 158-161.
[9] 梁文迪, 苏钰琦, 胡彪, 甘胤文, 黄卫超, 杨其霖. 高密度脂蛋白胆固醇和非酒精性脂肪肝发生的相关性——基于日本人群的一项横断面研究[J/OL]. 中华临床实验室管理电子杂志, 2021, 09(03): 154-159.
[10] 姚晨晨, 杨雷, 罗诚诚, 佘会. 低密度脂蛋白胆固醇联合甘油三酯与葡萄糖乘积指数在急性冠脉综合征患者发生主要心血管事件中的预测价值[J/OL]. 中华心脏与心律电子杂志, 2024, 12(01): 36-41.
[11] 蔡朝蓓, 陈倩倩, 令狐恩强. 辅助牵引技术在消化道肿瘤超级微创手术中的研究进展[J/OL]. 中华胃肠内镜电子杂志, 2024, 11(01): 52-55.
[12] 鲍颖慧, 李伯妍, 周宁, 尹晓岳, 赵敏, 朱国宁, 刘淼, 何耀. 基于卫生经济学评价报告标准评价消化道肿瘤微创手术卫生经济学研究的报告规范性[J/OL]. 中华胃肠内镜电子杂志, 2024, 11(01): 41-46.
[13] 郝婧, 阳柳柳, 韩优, 张晓. 围手术期消化道肿瘤患者营养风险与营养支持情况研究[J/OL]. 中华胃肠内镜电子杂志, 2022, 09(03): 130-133.
[14] 刘玉苓, 王婷婷, 吴高峰, 俞淑静. 健康体检人群内脏脂肪面积与新型炎症标志物的相关性研究[J/OL]. 中华肥胖与代谢病电子杂志, 2023, 09(03): 197-202.
[15] 李洪远, 董书宇, 鹿寒冰. 血清Hcy、sdLDL-C、Lp-PLA2水平对短暂性脑缺血发作进展为急性脑梗死的预测效能[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(01): 40-48.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?